Alnylam Pharmaceuticals, Inc. (FRA:DUL)
285.30
-2.10 (-0.73%)
At close: Feb 20, 2026
18.23% (1Y)
| Market Cap | 37.85B +10.6% |
| Revenue (ttm) | 3.16B +65.2% |
| Net Income | 267.22M |
| EPS | 1.98 |
| Shares Out | n/a |
| PE Ratio | 141.63 |
| Forward PE | 33.60 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 4 |
| Open | 287.10 |
| Previous Close | 287.40 |
| Day's Range | 285.30 - 290.00 |
| 52-Week Range | 198.70 - 423.00 |
| Beta | n/a |
| RSI | 45.93 |
| Earnings Date | Feb 12, 2026 |